On August 19, 2020, GI Windows Medical Corp, a clinical-stage, privately held medical device company, announced a $16.4 million Series A-1 financing. The financing attracted Johnson & Johnson Innovation – JJDC, Inc., along with Sonder Capital, GT Healthcare, JC Investco, and one additional strategic investor.

In addition to the institutional financing, GI Windows received investments from existing shareholders as well as new investors the Kennedy Trust and Coleman Trust. The proceeds will be used to support further product development and clinical studies for GI Window’s patented technology.

The Wilson Sonsini Goodrich & Rosati team that represented GI Windows in the transaction includes Mark Solakian, Jake Gatof, and Priyanka Nawathe.

For more information, please see GI Windows' press release.